Company / Operating Income
ATOSSA THERAPEUTICS, INC. Operating Income History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$12.8M
FY2016
5-year range
-$12.8M / -$3.4M
FY2012-FY2016
Trend
-4.8%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 4 consecutive years, from -$3M in FY2012 to -$13M in FY2016.
Based on SEC 10-K filings.
-$13M in FY2016.
Declined from -$11M to -$13M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ATOSSA THERAPEUTICS, INC.'s operating income has declined for 4 consecutive years.
- In FY2016, operating income decreased 4.8% year-over-year.
- Peak operating income was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$12.8M | -4.8% |
| FY2015 | -$12.2M | -12.9% |
| FY2014 | -$10.8M | -112.8% |
| FY2013 | -$5.1M | -47.8% |
| FY2012 | -$3.4M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026